Acutus Medical, Inc.
AFIB Healthcare Medical Devices
In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
Follow AFIB
Acutus Medical, Inc. (AFIB) Piotroski F-score
Acutus Medical, Inc.'s Piotroski F-score for fiscal 2024 is 3 out of 9: 3 of nine tests of profitability, leverage and efficiency passed, unchanged from fiscal 2023.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2024 | 3 | 0.00 |
| FY2023 | 3 | 0.00 |
| FY2022 | 3 | (1.00) |
| FY2021 | 4 | (2.00) |
| FY2020 | 6 | — |
How fiscal 2024’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (23.11%) | (87.15%) | Fail | 0 |
| Positive operating cash flow | (31.66m) | (63.12m) | Fail | 0 |
| Rising return on assets | (23.11%) | (87.15%) | Pass | 1 |
| Cash flow above net income | (22.11m) | 18.55m | Fail | 0 |
| Falling long-term leverage | 0.62 | 0.35 | Fail | 0 |
| Rising current ratio | 2.06 | 2.44 | Fail | 0 |
| No new shares issued | 29,768,000 | 29,095,000 | Fail | 0 |
| Rising gross margin | 5.03% | (43.79%) | Pass | 1 |
| Rising asset turnover | 0.49 | 0.08 | Pass | 1 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 3 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| XAIR Beyond Air, Inc. compare | 5 |
| NXL Nexalin Technology, Inc. compare | 5 |
| DHAI DIH Holding US, Inc. compare | 4 |
| BIOLQ Biolase, Inc. compare | 3 |
| VJET Flyte Aviation, Inc. compare | 3 |
| AFIB Acutus Medical, Inc. | 3 |
| NUWE Nuwellis, Inc. compare | 3 |
| DYNTQ Dynatronics Corporation compare | 3 |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover